ArticleWorld journal of transplantation2025

Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation.

Ileana Lulic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.